Clinical considerations of leukotriene modifiers in the treatment of rhinitis
- 1 November 2001
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy Reviews
- Vol. 1 (3) , 235-243
- https://doi.org/10.1046/j.1472-9725.2001.00003.x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flowClinical and Experimental Allergy, 2000
- Allergen-Stimulated Leukotriene B4 and Interleukin-8 Levels in Patients with Asthma and Allergic Rhinitis-Modulation by a Lipid Pathway InhibitorAnnals of Allergy, Asthma & Immunology, 1998
- Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapyJournal of Allergy and Clinical Immunology, 1996
- Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase InhibitorNew England Journal of Medicine, 1990
- Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reactionJournal of Allergy and Clinical Immunology, 1989
- Leukotriene B4 as a mediator of early and late reactions to antigen in humans: The effect of systemic glucocorticoid treatment in vivoJournal of Allergy and Clinical Immunology, 1989
- Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.Journal of Clinical Investigation, 1985
- Inflammatory Mediators in Late Antigen-Induced RhinitisNew England Journal of Medicine, 1985
- Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to RagweedNew England Journal of Medicine, 1984
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983